Bellerophon Therapeutics
BLPH
$0.05620
Share price
0.00%
Change (1 day)
-99.36%
Change (1 year)
Categories
Bellerophon Therapeutics (BLPH) - Total debt
Total debt on the balance sheet as of September 2023 : N/A
According to Bellerophon Therapeutics 's latest financial reports the company's total debt is N/A. A company’s total debt is the sum of all current and non-current debts.
Bellerophon Therapeutics - Total debt on balance sheet (from 2018 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | $0.2 M | -78.74% |
| 2021-12-31 | $0.95 M | -42.47% |
| 2020-12-31 | $1.66 M | -28.36% |
| 2019-12-31 | $2.31 M | |
| 2018-12-31 | $N/A |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Abbott Laboratories ABT | $15.62 B | N/A | 🇺🇸 USA |
 Baxter BAX | $14.17 B | N/A | 🇺🇸 USA |
 Lantheus Holdings LNTH | $0.61 B | N/A | 🇺🇸 USA |
 Abeona Therapeutics
ABEO | $5.4 M | N/A | 🇺🇸 USA |